Indirect comparisons of competing interventions.
By A. Glenny, Douglas G. Altman, F. Song, C. Sakarovitch, J. Deeks, R. D'amico, M. Bradburn, A. Eastwood. Health Technology Assessment, 2005
725 citations recorded by the source corpus.
OBJECTIVES To survey the frequency of use of indirect comparisons in systematic reviews and evaluate the methods used in their analysis and interpretation. Also to identify alternative statistical approaches for the analysis of indirect comparisons, to assess the properties of different statistical methods used for performing indirect comparisons and to compare direct and indirect estimates of the same effects within reviews. DATA SOURCES Electronic databases. REVIEW METHODS The Database of Abstracts of Reviews of Effects (DARE) was searched for systematic reviews involving meta-analysis of randomised controlled trials (RCTs) that reported both direct and indirect comparisons, or indirect comparisons alone. A systematic review of MEDLINE and other databases was carried out to identify published methods for analysing indirect comparisons. Study designs were created using data from the International Stroke Trial. Random samples of patients receiving aspirin, heparin or placebo in 16 centres were used to create meta-analyses, with half of the trials comparing aspirin and placebo and half heparin and placebo. Methods for indirect comparisons were used to estimate the contrast between aspirin and heparin. The whole process was repeated 1000 times and the results were compared with direct comparisons and also theoretical results. Further detailed case studies comparing the results from both direct and indirect comparisons of the same effects were undertaken. RESULTS Of the reviews identified through DARE, 31/327 (9.5%) included indirect comparisons. A further five reviews including indirect comparisons were identified through electronic searching. Few reviews carried out a formal analysis and some based analysis on the naive addition of data from the treatment arms of interest. Few methodological papers were identified. Some valid approaches for aggregate data that could be applied using standard software were found: the adjusted indirect comparison, meta-regression and, for binary data only, multiple logistic regression (fixed effect models only). Simulation studies showed that the naive method is liable to bias and also produces over-precise answers. Several methods provide correct answers if strong but unverifiable assumptions are fulfilled. Four times as many similarly sized trials are needed for the indirect approach to have the same power as directly randomised comparisons. Detailed case studies comparing direct and indirect comparisons of the same effect show considerable statistical discrepancies, but the direction of such discrepancy is unpredictable. CONCLUSIONS Direct evidence from good-quality RCTs should be used wherever possible. Without this evidence, it may be necessary to look for indirect comparisons from RCTs. However, the results may be susceptible to bias. When making indirect comparisons within a systematic review, an adjusted indirect comparison method should ideally be used employing the random effects model. If both direct and indirect comparisons are possible within a review, it is recommended that these be done separately before considering whether to pool data. There is a need to evaluate methods for the analysis of indirect comparisons for continuous data and for empirical research into how different methods of indirect comparison perform in cases where there is a large treatment effect. Further study is needed into when it is appropriate to look at indirect comparisons and when to combine both direct and indirect comparisons. Research into how evidence from indirect comparisons compares to that from non-randomised studies may also be warranted. Investigations using individual patient data from a meta-analysis of several RCTs using different protocols and an evaluation of the impact of choosing different binary effect measures for the inverse variance method would also be useful.
Subfields: General Health Professions, Statistics and Probability
View Paper: https://www.semanticscholar.org/paper/573735d74c33e3cc94db6f3e8c1d88dd2e7705f1
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In General Health Professions
- Johannes B Reitsma
- Karel G. M. Moons
- Joseph Lau
- S. Dias
- A. Sutton
- T. Debray
- A. Ades
- Thomas A. Trikalinos
In Statistics and Probability
- Georgia Salanti
- Ian R. White
- N. Welton
- A. Ades
- S. Dias
- G. van Valkenhoef
- D. Caldwell
- Julian P. T. Higgins
Citations in the corpus
- Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program. (2011, background): “Investigators should also note that simple adjusted indirect comparisons are generally underpowered, needing four times as many equally sized studies to achieve the same power as direct comparisons, and frequently lead to indeterminate results with wide CIs [15,17].”
- Evidence Synthesis for Decision Making 4 (2013, background): “Network meta-analysis (NMA), also referred to as mixed treatment comparisons or multiple treatment meta-analysis, combines information from multiple randomized comparisons of treatments A versus B, A versus C, B versus C, A versus D, and so on, while preserving randomization.(7) Given a connected ne”
- NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials (2011, background): “Rather than pooling information on trials comparing treatments A and B, network meta-analysis combines data from randomised comparisons, A vs B, A vs C, A vs D, B vs D, and so on, to deliver an internally consistent set of estimates while respecting the randomisation in the evidence.(24) Our common ”
- Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2. (2011, methodology): “Frequentist approaches have een developed by Lumley [18] in R using linear mixed models and re also feasible in SAS using PROC NLMIXED [38].”
- Evidence Synthesis for Decision Making 2 (2013, background): “, to deliver an internally consistent set of estimates while respecting the randomization in the evidence.(10) NMA is particularly useful in decisionmaking contexts.”
- GetReal in network meta‐analysis: a review of the methodology (2016, background): “In the past few years, NMA has become increasingly popular (Coleman et al., 2012; D’Ascenzo and Biondi-Zoccai, 2014; Donegan et al., 2010; Glenny et al., 2005; Nikolakopoulou et al., 2014; Sobieraj et al., 2013), and several published articles have discussed its advantages and limitations (Cipriani…”